Triplebar
Americas
Emeryville
,
United States
Startup
FOUNDED
2019
HEADCOUNT
2-20
FUNDING
Series A
Keywords:
AI/ML, microfluidics, HTP_screening, mammalian_cells, therapeutics, food_protein
BUSINESS
Applies AI, microfluidics, and ultra-high-throughput screening to engineer cell lines and strains for biologics and sustainable food proteins. In September 2024, the company announced a strategic pivot to concentrate on developing a predictive genomic language model.
BIOTECH INVOLVEMENT
Core; AI-driven synthetic biology platform for rapid biological optimization and discovery.
TECHNOLOGY PLATFORM
microfluidics; AI models (ESM3/AlphaFold); genome language models; high-throughput screening
PRIMARY PRODUCTS
eiCHO cell line; TCR-based T-cell therapies; optimized strains for food proteins